摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2Z,5Z)-N-[5-({2-[(3-fluoro-4-hydroxyphenyl)azamethylene]-4-oxo-1,3-thiazolidin-5-ylidene}methyl)-1,3-thiazol-2-yl]acetamide | 1253209-80-1

中文名称
——
中文别名
——
英文名称
(2Z,5Z)-N-[5-({2-[(3-fluoro-4-hydroxyphenyl)azamethylene]-4-oxo-1,3-thiazolidin-5-ylidene}methyl)-1,3-thiazol-2-yl]acetamide
英文别名
N-[5-[(Z)-[2-(3-fluoro-4-hydroxyphenyl)imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl]-1,3-thiazol-2-yl]acetamide
(2Z,5Z)-N-[5-({2-[(3-fluoro-4-hydroxyphenyl)azamethylene]-4-oxo-1,3-thiazolidin-5-ylidene}methyl)-1,3-thiazol-2-yl]acetamide化学式
CAS
1253209-80-1
化学式
C15H11FN4O3S2
mdl
——
分子量
378.408
InChiKey
WTNBOECCPJTMEO-XGICHPGQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    157
  • 氢给体数:
    3
  • 氢受体数:
    8

文献信息

  • THIAZOLIDINONE DERIVATIVE
    申请人:Irie Takayuki
    公开号:US20110190299A1
    公开(公告)日:2011-08-04
    An object of the present invention is to provide thiazolidinone derivatives. More specifically, an object of the present invention is to provide novel compounds having a CDC7 inhibitory action. The present invention provides thiazolidinone derivatives represented by the formula (I) The compounds of the present invention inhibit the CDC7 protein kinase activity, and suppress cell proliferation.
    本发明的目的是提供噻唑烷酮衍生物。更具体地,本发明的目的是提供具有CDC7抑制作用的新化合物。本发明提供由式(I)表示的噻唑烷酮衍生物。本发明的化合物抑制CDC7蛋白激酶活性,并抑制细胞增殖。
  • N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
    申请人:——
    公开号:US20040049043A1
    公开(公告)日:2004-03-11
    The present invention relates to selected glycidyl or carbonyl functional N-alkoxy-4,4-dioxy-polaylkyl-piperidine compounds forming an open chain or cyclic ketal structure, a polymerizable composition comprising a) at least one ethylenically unsaturated monomer and b) a glycidyl or carbonyl functional N-alkoxy-4,4-dioxy-polyalkyl-piperidine nitroxide initiator compound. Further aspects of the present invention are a process for polymerizing ethylenically unsaturated monomers and the use of glycidyl or carbonyl functional N-alkoxy-4,4-dioxy-polyalkyl-piperidine nitroxide initiators for radical polymerization.
    本发明涉及选择的含有环氧基或羰基基团的N-烷氧基-4,4-二氧-聚烯烃-哌啶化合物,形成开链或环状的酮缩结构,一种聚合物组合物,包括a)至少一种乙烯基不饱和单体和b)含有环氧基或羰基基团的N-烷氧基-4,4-二氧-聚烯烃-哌啶自由基引发剂化合物。本发明的进一步方面包括聚合乙烯基不饱和单体的方法以及使用含有环氧基或羰基基团的N-烷氧基-4,4-二氧-聚烯烃-哌啶自由基引发剂进行自由基聚合的方法。
  • [EN] CATIONIC ALKOXYAMINES AND THEIR USE IN PRODUCING NANO PARTICLES FROM NATURAL OR SYNTHETIC CLAYS<br/>[FR] ALKOXYAMINES CATIONIQUES ET UTILISATION DANS LA PRODUCTION DE NANOPARTICULES A PARTIR D'ARGILES NATURELLES OU SYNTHETIQUES
    申请人:CIBA SC HOLDING AG
    公开号:WO2004000809A1
    公开(公告)日:2003-12-31
    The instant invention relates to cationic alkoxyamines, which are useful as polymerization initiators/regulators in a controlled stable free radical polymerization process to produce intercalated and/or exfoliated nanoparticles from natural or synthetic clays. The invention also relates to improved nanocomposites produced by this process and to the use of these nanocomposite compositions as, for example, coatings, sealants, caulks, adhesives and as plastic additives.
    该瞬时发明涉及阳离子烷氧胺,其在受控稳定自由基聚合过程中作为聚合引发剂/调节剂,用于从天然或合成黏土中产生层间和/或剥离的纳米粒子。该发明还涉及通过这一过程生产的改进纳米复合材料,以及将这些纳米复合物组合物用作例如涂料、密封剂、填缝剂、粘合剂和塑料添加剂。
  • Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
    申请人:Muhlebach Andreas
    公开号:US20050215691A1
    公开(公告)日:2005-09-29
    The instant invention relates to cationic alkoxyamines, which are useful as polymerization initiators/regulators in a controlled stable free radical polymerization process to produce intercalated and/or exfoliated nanoparticles from natural or synthetic clays. The invention also relates to improved nanocomposites produced by this process and to the use of these nanocomposite compositions as, for example, coatings, sealants, caulks, adhesives and as plastic additives.
    本发明涉及阳离子烷氧胺,它们在受控稳定自由基聚合过程中作为聚合引发剂/调节剂,用于从天然或合成黏土中生产插层和/或剥离纳米颗粒。本发明还涉及通过该过程生产的改进纳米复合材料以及将这些纳米复合材料组成物用作涂料、密封剂、填缝剂、粘合剂和塑料添加剂等的用途。
  • 4-Imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators
    申请人:——
    公开号:US20040176553A1
    公开(公告)日:2004-09-09
    The present invention relates to selected 4-imino-N-alkoxy-polyalkyl-peperidine compounds preparation, a polymerizable composition comprising a) at least one ethylenically unsaturated monomer and b) a 4-imino-N-alkoxy-polyalkyl-piperidine compound. Further aspects of the present invention are a process for polymerizing ethylenically unsaturated monomers, and the use of 4-imino-N-alkoxy-polyalkyl-piperidine compounds for controlled polymerization. The intermediate N-oxyl derivatives, a composition of the N-oxyl derivatives with ethylenically unsaturated monomers and a free radical initiator, as well as a process for polymerization are also subjects of the present invention. 1
    本发明涉及选择的4-亚基-N-烷氧基-聚烷基-哌啶化合物的制备,包括a)至少一种乙烯基不饱和单体和b)4-亚基-N-烷氧基-聚烷基-哌啶化合物的可聚合组合物。本发明的其他方面包括聚合乙烯基不饱和单体的过程,以及使用4-亚基-N-烷氧基-聚烷基-哌啶化合物进行控制聚合的方法。中间体N-氧代衍生物,N-氧代衍生物乙烯基不饱和单体和自由基引发剂的组合物,以及聚合的过程也是本发明的主题。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫